Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari, R Lessells… - Journal of …, 2020 - academic.oup.com
Objectives To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …
被引用次数：12 相关文章

[引用][C] Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari… - Journal of …, 2020 - espace.library.uq.edu.au
Objectives: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.

B Chimukangara, J Giandhari, R Lessells… - The Journal of …, 2020 - europepmc.org
Objectives To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.

B Chimukangara, J Giandhari, R Lessells… - 2020 - cabidigitallibrary.org
Objectives: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …
[PDF] oup.com

[PDF][PDF] Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari, R Lessells… - Journal of …, 2020 - academic.oup.com
Objectives To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …
[PDF] researchgate.net

[PDF][PDF] Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari, R Lessells… - 2020 - researchgate.net
OBJECTIVES: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …
[HTML] nih.gov

[HTML][HTML] Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari, R Lessells… - Journal of …, 2020 - ncbi.nlm.nih.gov
Objectives To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.

B Chimukangara, J Giandhari… - The Journal of …, 2020 - researchonline.lshtm.ac.uk
OBJECTIVES: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …
[PDF] archive.org

[PDF][PDF] Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals

B Chimukangara, J Giandhari, R Lessells… - 2020 - scholar.archive.org
OBJECTIVES: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant
variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals …

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.

B Chimukangara, J Giandhari, R Lessells… - The Journal of …, 2020 - sonar.ch
METHODS We conducted a case-control study of 170 adults with HIV-1/TB co-infection.
Cases had at least one viral load (VL)≥ 1000 RNA copies/mL after≥ 6 months on NNRTI …